Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06781333
PHASE2

Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.

Sponsor: Bernard (Barry) Baumel

View on ClinicalTrials.gov

Summary

The purpose of this research study is to test if adding one infusion of mesenchymal stem cells to the current treatment with antipsychotic medication may help control behavioral problems in people with a diagnosis of moderate to severe Alzheimer's disease.

Official title: A Pilot Study to Assess the Effect of Adding 1 Infusion of Human Mesenchymal Stem Cells (hMSC) to the Treatment of Patients Suffering Agitation/Aggression or Other Behavioral Abnormalities From Alzheimer's Disease.

Key Details

Gender

All

Age Range

55 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

8

Start Date

2025-04-29

Completion Date

2026-06-15

Last Updated

2025-05-29

Healthy Volunteers

No

Interventions

BIOLOGICAL

hMSC

Participants will come in person to receive one intravenous infusion of approximately 25 million cells up to 20 minutes.

Locations (1)

University of Miami Department of Neurology

Miami, Florida, United States